ACTA1 and Hepatic fibrosis: Consistent with our findings, previous studies demonstrated that FZHY could inhibit HSC activation [31,32], decrease α-SMA protein expression and Col-1 secretion in liver fibrosis induced by chemical toxin in rats [2,33].